Recently Pharmig ran a session on cleaning validation. Here are some of the questions posed, together with the answers.
This
is obviously not easy. If the surface area is smaller, then the count is still
assessed as if it was 25cm2 (to indicate what a ‘norm’ is and to
allow a comparison to be made). With other areas, all you can do is gain an
approximate assessment in terms of the number and length of strokes. It is
generally accepted that where a template cannot be used, the swabbing is
approximate.
How can a swab
template be used for the irregular surfaces? If not, what justification may be
used?
A
swab template cannot be used on an irregular surface, all you can do is gain an
approximate assessment in terms of the number and length of strokes. It is
generally accepted that where a template cannot be used, the swabbing is
approximate.
Where
you can, it is best to use a contact plate – it gives a better recovery and if
there are cleaning residues present, the agar can contain an appropriate
neutralisers.
Are there any
regulations or guidelines for swabbing in this manner?
Not
for microbiological swabbing. There are a number of good guidance texts,
although these are not ‘standards’. The microbiological aspects are invariably
overlooked, which was the reason for putting the webinar together.
I’d
recommend the work of Andrew Walsh, for example: https://pbe-expert.com/wp-content/uploads/2018/04/CleaningValidationforthe21stCentury-AcceptanceLimitsforCleaningAgents.pdf
How can training
be provided for personnel to encompass this irregular swabbing?
Pharmig
have run too training courses run by Gordon Farquharson in relation to this.
The
best way is to use old items of equipment and allow personnel to practice on
the lab bench, assessing their technique e.g. number of swab strokes, twisting
the swab head etc.
Also when swabbing
a surface do companies use cut out templates to get an accurate surface area?
Or do companies just go on samplers judgement of surface area- between
different samplers this could introduce a lot of variability?
Some
companies use templates, which are sterilised. These will only work on
relatively flat, regular shaped surfaces.
Others
use judgement, and this has to be applied to irregular shaped surfaces. This
can be supported by training.
As cannot
contaminate equipment with organisms like can with chemicals. What does he
think to the suggestion of supplementing cleaning validation study with lab
based studies on samples of surfaces representative of the equipment? E.g.
samples of SS 316L in lab – could contaminate with organism(s) representative
of those found in facility and demonstrate effectiveness of cleaning
regime/agents etc. is possible. Overkill
& unnecessary or good to do if have the time & resource?
This
is useful if there is sufficient resource. The method outlined is similar to
disinfectant efficacy testing in terms of phase 2 surface evaluation. However,
it is not (as yet) a regulatory requirement. The standard approach is to
evaluate ‘cleanliness’ through direct (swabbing) and indirect (rinse) samples.
The
reference to facility isolates is interesting, although these are difficult to
standardise.
Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)
No comments:
Post a Comment
Pharmaceutical Microbiology Resources